Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease

@inproceedings{Ma2015CombinationOT,
  title={Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease},
  author={Ruixia Ma and Yan Xu and Wei Jiang and Wei Zhang},
  booktitle={Biotechnology, biotechnological equipment},
  year={2015}
}
The aim of this study was to investigate whether Tripterygium wilfordii Hook F (TwHF) and irbesartan could synergistically affect the urinary excretion of podocytes and proteins in type 2 diabetic kidney disease (DKD) patients and the underlying mechanisms. Forty DKD patients were divided into a DI group (DKD patients treated with irbesartan alone) and a DTI group (DKD patients treated with Tripterygium wilfordii Hook F and irbesartan). Urinary podocytes were observed by immunofluorescence… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Effects of triptolide on the podocyte protein expression of nephrin and podocin and its mechanism in type 2 diabetic rats

  • RX Ma, XM Liu, LQ Liu, HN. Li
  • Chin J Diabetes
  • 2010
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…